Treatment of Oral Thrush in a 5-Month-Old Infant
For a 5-month-old infant with oral thrush, the recommended first-line treatment is nystatin oral suspension 1 mL (100,000 units/mL) four times daily for 7-14 days. 1, 2
First-Line Treatment Options
- Nystatin oral suspension (100,000 units/mL): Administer 1 mL four times daily for 7-14 days, placing half the dose in each side of the mouth and avoiding feeding for 5-10 minutes afterward 1, 2
- Treatment should continue for at least 48 hours after perioral symptoms have disappeared and cultures demonstrate eradication of Candida albicans 2
Alternative Treatment Options
Fluconazole oral suspension: 3-6 mg/kg once daily for 7 days if nystatin is ineffective or not tolerated 1, 3
Miconazole oral gel: 15 mg every 8 hours, which has demonstrated higher clinical cure rates (84.7% by day 5) compared to nystatin (21.2% by day 5) 1, 4
Special Considerations for Breastfeeding Infants
- If the infant is breastfed and the mother has symptoms of nipple candidiasis, simultaneous treatment of both mother and infant is recommended 1, 5
- For the mother, apply miconazole cream to the nipples/areola after each feeding 5
- Continue treatment for the full prescribed duration, even if symptoms resolve earlier, to prevent recurrence 5
Duration of Treatment
- Continue nystatin treatment for 7-14 days 1, 2
- Treatment should continue for at least 48 hours after clinical resolution of symptoms 2
- The endpoint of treatment should be mycological rather than just clinical cure 6
Monitoring and Follow-up
- Monitor for clinical improvement within 5-7 days of starting treatment 4
- If no improvement is seen after 7 days of nystatin therapy, consider switching to an alternative agent such as fluconazole 1, 3
- For persistent cases, evaluate for potential underlying conditions or consider extending the treatment duration 6
Precautions
- In premature infants, monitor for potential adverse effects of nystatin, such as intestinal damage and necrotizing enterocolitis 1
- Be aware that miconazole oral gel use may potentially lead to the development of triazole resistance 1